💊 MariTide and Orforglipron make strides
Trials are going well -- no new negative side effects to mention and great results.
With all the announcements coming out of the ADA 85th Science Sessions conference, it’s easy to get lost in the flow of news.
We took some time to dive in to the announcements made at the conferences and by respective companies with regards to progress these drugs have made in trials (Phase 2 and Phase 3).